MedTrace Logo

Applying Population Management Best Practices to Preventative Genomic Medicine Trial

NCT07053813 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 900

Last updated 2026-02-27

No results posted yet for this study

Summary

Preventive genomic medicine, particularly identification of individuals with inherited cancer risk, can improve longevity and quality of life, yet adherence to risk management following cancer genomic testing is poor. The proposed research refines and evaluates two highly scalable population management interventions, web resources and personalized outreach, designed to improve access and use of recommended risk management following cancer genetic testing. Research activities will be conducted in a vertically integrated health system and federally qualified health center and will address post-testing quality and patient safety concerns that are minimizing patient benefit and slowing investments in real world genomic medicine implementation.

Conditions

  • Neoplastic Syndromes, Hereditary

Interventions

BEHAVIORAL

Web resources

Mailed educational resources through portal and USPS mail

BEHAVIORAL

Personalized outreach

Phone call to discuss due and overdue screening and other personalized risk management recommendations

Sponsors & Collaborators

Principal Investigators

  • Sarah Knerr, PhD, MPH · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2027-07-01
Completion
2028-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07053813 on ClinicalTrials.gov